SecBot SecBot
SC 13G ·Filed Nov 9, 2026

EXEL

EXELIXIS, INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed7d 5h ago SEC0000908834-26-000516
Passive investor 5%+ stake
Actionable Insight • Neutral

Farallon's new passive stake signals conviction in Exelixis following strong Q3 results and maintained guidance. Monitor for any future 13D conversion or additional accumulation, though the filing explicitly disclaims activist intent.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$70.58
T+0 close · Nov 9, 2026 · via day close
Latest settled
+0.17%
T+1 · $70.70 · next T+5 in 7h
Vs SPY
−1.15%
α at T+1
Latest observation
−3.69%
T+4 · FF3 residual α
  1. T+0 · Nov 10 $70.58entry
  2. T+1 · 6d ago +0.17%α −1.15% · $70.70
  3. T+4 · todayOpen
  4. T+5 · in 7h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Farallon Capital Management disclosed a new 5%+ passive stake in Exelixis, reporting beneficial ownership of 14,694,910 shares (approximately 4.7% of shares outstanding based on the $16.8B market cap and snapshot price). The filing certifies passive intent under Rule 13d-1(b) and follows Exelixis's Q3 2026 earnings beat and maintained guidance.

Key Financial Metrics

Stake
4.7%
Investor
Farallon Capital Management, L.L.C.
Investor Type
hedge fund

Key Facts

  • Farallon Capital Management filed a new Schedule 13G disclosing beneficial ownership of 14,694,910 shares of Exelixis common stock
  • The filing certifies passive intent under Rule 13d-1(b), with no purpose or effect of changing or influencing control
  • Shares are held through eight Farallon investment partnerships including Farallon Capital Partners, L.P. and Farallon Capital Institutional Partners, L.P.
  • Farallon is a hedge fund manager; this is a new 13G filing (not an amendment) for Exelixis
  • Exelixis reported Q3 2026 revenue of $658.7M (up 10.2% YoY) and GAAP diluted EPS of $0.85 (up 23.2% YoY) on October 29, 2026

Financial Impact

14,694,910 shares disclosed; approximately 4.7% of shares outstanding based on $16.8B market cap and snapshot price

ownershipshare count

Risk Factors

  • No specific risks identified from this passive 13G filing
  • Farallon could increase or decrease position without additional disclosure until crossing 5% thresholds

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
46% bullish (24 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000908834-26-000516
Document: 0000908834-26-000516-index-headers.html0000908834-26-000516
Document: 0000908834-26-000516-index.html0000908834-26-000516
Document: 0000908834-26-000516.txt0000908834-26-000516

Track record

16 reports on EXEL

Performance horizon

0 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +21.97% at T+60 after the Feb 28, 2026 report. 1 of 3 went positive at some point.

Filters
  1. Nov 9, 20267d ago SC 13G Neutral 3/10 Viewing Entry $70.58 to $70.70 Now $67.10 −4.93% ▲ +0.17% −1.15% vs SPY
  2. Nov 9, 20267d ago SC 13D/A Bearish 5/10 Entry $70.58 to $70.70 Now $67.10 +4.93% ▼ −0.17% +1.15% vs SPY
  3. Oct 29, 202618d ago 8-K Neutral 5/10 Entry $69.39 to $70.13 Now $67.10 −3.30% ▲ +1.07% +1.55% vs SPY
  4. Oct 20, 202627d ago Institutional Cluster Neutral 2/10 Entry $64.58 to $65.31 Now $67.10 +3.90% ▲ +1.13% +2.31% vs SPY
  5. Oct 12, 20265w ago Institutional Cluster Neutral 3/10 Entry $59.82 to $59.51 Now $67.10 +12.17% ▼ −0.52% −0.51% vs SPY
  6. Sep 11, 20269w ago 8-K Bearish 6/10 Entry $56.12 to $56.21 Now $67.10 −19.57% ▼ −0.16% −0.61% vs SPY
  7. Jun 3, 202623w ago Insider Cluster Neutral 2/10 Entry $52.39 to $52.69 Now $67.10 +28.08% ▲ +0.57% +3.17% vs SPY
  8. May 29, 202624w ago 8-K Neutral 3/10 Entry $50.20 to $48.49 Now $67.10 +33.67% ▼ −3.41% −3.55% vs SPY
  9. May 28, 202624w ago Insider Cluster Neutral 3/10 Entry $50.32 to $50.28 Now $67.10 +33.35% ▼ −0.08% −0.35% vs SPY
  10. May 28, 202624w ago Insider Cluster Neutral 3/10 Entry $50.32 to $50.28 Now $67.10 +33.35% ▼ −0.08% −0.35% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 9h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026